Key result
Online familial hypercholesterolemia resources explain the condition well but lack clear care and referral pathways.
Why the study?
Approximately 90% of individuals with familial hypercholesterolaemia remain undiagnosed and primary care referral rates for specialist assessment and family cascade screening remain low, prompting an evaluation of the scope and quality of online FH information available to primary care providers.
Systematic Review (n=23)
Australian online resources for primary care providers adequately describe clinical features of familial hypercholesterolaemia but lack critical guidance on referral processes, care pathways, and cascade screening.
Answers are grounded in this paper and cite their sources.
May impede primary care FH diagnosis via inadequate online guidance; extends evidence on global underdiagnosis by identifying specific Australian resource gaps.
Background Familial hypercholesterolaemia (FH) is a common inherited condition that leads to elevated low-density lipoprotein (LDL) cholesterol levels, significantly increasing the risk of cardiovascular disease. Despite the World Health Organization’s (WHO) recognition of FH as a major public health concern in 1998 and recommendations for early diagnosis and management, FH remains one of the most underdiagnosed conditions globally. Approximately 90% of individuals with FH remain undiagnosed. Primary care providers are pivotal in FH diagnosis and management, yet referral rates for specialist assessment and family cascade screening remain low. Methods Medical associations, genetic testing laboratories, government agencies, research institutions and advocacy organisations have been working to foster an FH-focused informational environment within the broader context of cardiovascular disease prevention. This study evaluates the scope and quality of FH-related information available to primary care providers through the websites of organisations in clinical, research, regulatory and community sectors. Eligible web pages were written-format, publicly available, English-language sources published on Australian websites addressing FH genetic testing or cascade testing. The DISCERN-Genetics instrument, which assesses genomics-related content according to 20 topics, was used to assess scope and quality. The study focuses on Australian information environment as an example of a country with low FH detection rates in primary care despite existing frameworks, interventions and infrastructure to support risk assessment and genetic testing. Results A total of 23 web pages met the inclusion criteria after excluding duplicates and paywalled sites. Most pages were produced by consumer bodies and commercial pathology companies, followed by government agencies and research journals. Content scored highly for explanations of the condition and lower for care pathways, referrals procedures and patient-centred issues of privacy, implications of discrimination and psychosocial consequences of testing. Conclusions Current FH information lacks guidance for primary care providers on the care pathway from FH risk assessment and diagnosis to family cascade screening and preventative therapies. While clinical features of FH are adequately addressed, gaps in information about referral processes, genetic testing and the shared care role of primary care providers can contribute to the barriers that hinder FH diagnosis in Australia and globally. Improving online resources can facilitate awareness and engagement with FH in primary care, optimising the prevention of cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Lamprell et al. (2026) conducted a systematic review in Familial hypercholesterolaemia (n=23). DISCERN-Genetics instrument quality and scope assessment was evaluated on Scope and quality of familial hypercholesterolaemia-related online information assessed across 20 topics using the DISCERN-Genetics instrument. Online familial hypercholesterolaemia resources across 23 Australian web pages scored high on condition explanations but low on care pathways, referral procedures, and testing implications.
Synapse has enriched 10 related papers. Consider them for comparative context: